Donor | Diagnosis | Sex | Ethnicity | Disease duration (years) | RF | Medications | Origin of cells | Figures showing which cells were useda |
---|---|---|---|---|---|---|---|---|
RA-1 | RA | Female | White | 3 | + | NSAID | Asterand Bioscience | 1a, b; 2a, b; 3a, b, d |
RA-2 | RA | Male | Hispanic | <1 | + | Prednisone, DMARD | Asterand Bioscience | 2a, b; 5a, b, c; 6b |
RA-3 | RA | Female | White | <1 | + | NSAID | Asterand Bioscience | 2a, b; 3a, b, d |
RA-4 | RA | Female | White | 12 | + | NSAID, prednisone | Asterand Bioscience | 1a, b; 2a, b; 4c |
RA-5 | RA | Female | Hispanic | 2 | + | DMARD, NSAID | FITDP | 1a, b; 4a, b, e, f, g; 5a, b, c |
RA-6 | RA | Female | White | 21 | + | Prednisone, DMARD | FITDP | 3a, b, c, d |
RA-7 | RA | Female | White | 30 | + | Prednisone, DMARD | FITDP | 2a, b; 3a, b, c, d; 4c, d, e, f |
RA-8 | RA | Female | White | 20 | + | Etanercept, prednisone | FITDP | 1a, b; 2a, b |
RA-9 | RA | Female | White | 21 | + | Leflunomide, etanercept, prednisone | FITDP | 1a, b; 4a, b; 5a, b, c; 6a, b |
RA-10 | RA | Male | White | 15 | + | NSAID, prednisone, adalimumab | FITDP | 2a, b; 3c; 4c, d, e, f, g |
RA-11 | RA | Female | African American | 11 | + | Hydroxychloroquine, prednisone | FITDP | 2a, b; 3c; 4c, d, e, f, g |
RA-12 | RA | Male | White | >10 | + | Etanercept | FITDP | 1a, b; 3c; 4a, b |
RA-13 | RA | Female | Hispanic | >10 | + | Methotrexate, prednisone | FITDP | 3a, b, c, d; 4c, d, e, f; 6a, b |
RA-14 | RA | Female | White | 3 | + | Prednisone, methotrexate | FITDP | 5a, b, c; 6a, b |
OA-1 | OA | Female | White | 12 | − | None | Asterand Bioscience | 4c, d, e, f |
OA-2 | OA | Male | White | 16 | − | None | Asterand Bioscience | 4c, d, e, f |
OA-3 | OA | Male | White | 25 | N/A | None | FITDP | 4c, d, e, f |
OA-4 | OA | Male | White | 78 | N/A | None | FITDP | 4c, d, e, f |